Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response

Clinical Cancer Research

Volumn 5, Issue 3, 1999, Pages 673-680

  Young, Leah C ^a   Campling, Barbara G ^a   Voskoglou Nomikos, Theodora ^a   Cole, Susan P C ^a   Deeley, Roger G ^a   Gerlach, James H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE;

AREA UNDER THE CURVE; ARTICLE; CRYOPRESERVATION; DRUG RESPONSE; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, SMALL CELL; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION; GENES, MDR; HUMANS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033038623     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bradley, G., Juranka, P. F., and Ling, V. Mechanisms of multidrug resistance. Biochim. Biophys. Acta, 948: 87-128, 1988.
2. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. C., and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54: 357-361, 1994.
3. Cole, S. P. C. Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
4. Zaman, G. J. R., Flens, M. J., van Leusden, M. R., de Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., and Borst, P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA, 91: 8822-8826, 1994.
5. Stride, B. D., Grant, C. E., Loe, D. W., Hipfner, D. R., Cole, S. P. C., and Deeley, R. G. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. Mol. Pharmacol., 52: 344-353, 1997.
6. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
7. Loe, D. W., Deeley, R. G., and Cole, S. P. C. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer, 32A: 945-957, 1996.
8. Goldstein, L. J. MDR1 gene expression in solid tumours. Eur. J. Cancer, 32A: 1039-1050, 1996.
9. Nooter, K., de la Riviere, G. B., Look, M. P., van Wingerden, K. E., Henzen-Logmans, S. C., Scheper, R. J., Flens, M. J., Klijn, J. G. M., Stoter, G., and Foekens, J. A. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. Br. J. Cancer, 76: 486-493, 1997.
10. Nooter, K., de la Riviere, G. B., Klijn, J., Stoter, G., and Foekens, J. Multidrug resistance protein in recurrent breast cancer. Lancet, 349: 1885-1886, 1997.
11. Endo, K., Maehara, Y., Kusumoto, T., Ichiyoshi, Y., Kuwano, M., and Sugimachi, K. Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer. Int. J. Cancer, 68: 372-377, 1996.
12. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 231-238, 1996.
13. Norris, M. D., Bordow, S. B., Haber, P. S., Marshall, G. M., Kavallaris, M., Madafiglio, J., Cohn, S. L., Salwen, H., Schmidt, M. L., Hipfner, D. R., Cole, S. P. C., Deeley, R. G., and Haber, M. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma. Eur. J. Cancer, 33: 1911-1916, 1997.
14. Chan, H. L. S., Lu, Y., Grogan, T. M., Haddad, G., Hipfner, D. R., Cole, S. P. C., Deeley, R. G., Ling, V., and Gallie, B. L. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res., 57: 2325-2330, 1997.
15. Ota, E., Abe, Y., Oshika, Y., Iwasaki, M., Inoue, H., Yamazaki, H., Ueyema, Y., Takagi, K., Ogata, T., Tamaoki, N., and Nakamura, M. Expression of the multidrug resistance associated-protein (MRP) gene in non-small-cell lung cancer. Br. J. Cancer, 72: 550-554, 1995.
16. Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., and Kruh, G. D. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res., 58: 2741-2747, 1998.
17. Kiuchi, Y., Suzuki, H., Hirohashi, T., Tyson, C. A., and Sugiyama, Y. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett., 433: 149-152, 1998.
18. Allikmets, R., Gerrard, B., Hutchinson, A., and Dean, M. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the Expressed Sequence Tags database. Hum. Mol. Genet., 5: 1649-1655, 1996.
19. Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J. T., Juijn, J. A., Baas, F., and Borst, P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res., 57: 3537-3547, 1997.
20. Kartenbeck, J., Leuschner, U., Mayer, R., and Keppler, D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology, 23: 1061-1066, 1996.
21. Buchler, M., Konig, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., and Keppler, D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. Biol. Chem., 271: 15091-15098, 1996.
22. Mayer, R., Kartenbeck, J., Buchler, M., Jedlitschky, G., Leier, I., and Keppler, D. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol., 131: 137-150, 1995.
23. Keppler, D., and Konig, J. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J., 11: 509-516, 1997.
24. Narasaki, F., Oka, M., Nakano, R., Ikeda, K., Fukuda, M., Nakamura, T., Soda, H., Nakagawa, M., Kuwano, M., and Kohno, S. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells. Biochem. Biophys. Res. Commun., 240: 606-611, 1997.
25. Taniguchi, K., Wada, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S., and Kuwano, M. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res., 56: 4124-4129, 1996.
26. Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., and Oude Elferink, R. P. J. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (Washington DC), 271: 1126-1128, 1996.
27. Koike, K., Kawabe, T., Tanaka, T., Toh, S., Uchiumi, T., Wada, M., Akiyama, S., Ono, M., and Kuwano, M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res., 57: 5475-5479, 1997.
28. Campling, B. G., Haworth, A. C., Baker, H. M., Greer, D. L., Holden, J. J. A., Bradley, W. E. C., Pym, J., and Dexter, D. F. Establishment and characterization of a panel of human lung cancer cell lines. Cancer (Phila.), 69: 2064-2074, 1992.
29. Campling, B. G., Young, L. C., Baer, K., Lam, Y. M., Deeley, R. G., Cole, S. P. C., and Gerlach, J. H. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin. Cancer Res., 3: 115-122, 1997.
30. Carney, D. N., Gazdar, A. F., Bepler, G., Guccion, J. G., Marangos, P. J., Moody, T. W., Zweig, M. H., and Minna, J. D. Establishment and identification of small cell lung cancer lines having classic and variant features. Cancer Res., 45: 2913-2923, 1985.
31. Ellison, M. L., Hillyard, C. J., Bloomfield, G. A., Rees, L. H., Coombes, R. C., and Neville, A. M. Ectopic hormone production by bronchial carcinoma in culture. Clin. Endocrinol., 5: 397s-406s, 1976.
32. Fisher, E. R., and Paulson, J. D. A new in vitro line established from human large cell variant of oat cell lung cancer. Cancer Res., 38: 3830-3835, 1978.
33. Cole, S. P. C., Campling, B. G., Dexter, D. F., Holden, J. J., and Roder, J. C. Establishment of a human large cell lung tumor line (QU-DB) with metastatic properties in athymic mice. Cancer (Phila.), 58: 917-923, 1986.
34. Fogh, J., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.), Human Tumor Cells in Vitro, pp. 115-159. New York: Plenum Publishing Corp., 1975.
35. Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51: 1417-1423, 1973.
36. Anger, B., Brockman, R., Andreef, M., Erlanson, R., Jhanwar, S., Kameya, T., Saigo, P., and Wright, W. Characterization of two newly established human cell lines from patients with large-cell anaplastic lung carcinoma. Cancer (Phila.), 50: 1518-1529, 1982.
37. Wright, W. C., Daniels, W. P., and Fogh, J. Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis. J. Natl. Cancer Inst., 66: 239-247, 1981.
38. Campling, B. G., Pym, J., Baker, H. M., Cole, S. P. C., and Lam, Y. M. Chemosensitivity testing of small cell lung cancer using the MTT assay. Br. J. Cancer, 63: 75-83, 1991.
39. Lam, Y. M., Pym, J., and Campling, B. G. Dose response analysis of chemosensitivity testing of small cell lung cancer using the MTT assay. Proc. Biopharm. Sect. Am. Stat. Assoc, 193-198, 1989.
40. Wright, S. W., Boag, A. H., Valdimarsson, G., Hipfner, D. R., Campling, B. G., Cole, S. P. C., and Deeley, R. G. Immunohistochemical detection of multidrug resistance protein (MRP) in human lung cancer and normal lung. Clin. Cancer Res., 4: 2279-2289, 1998.
41. Giaccone, G., van Ark-Otte, J., Rubio, G. J., Gazdar, A. F., Broxterman, H. J., Dingemans, A. C., Flens, M. J., Scheper, R. J., and Pinedo, H. M. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell cancer and in normal lung. Int. J. Cancer, 66: 760-767, 1996.
42. Berger, W., Elbling, L., Hauptmann, E., and Micksche, M. Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells. Int. J. Cancer, 73: 84-93, 1997.
43. Oude Elferink, R. P. J., and Jansen, P. L. M. The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol. Ther., 64: 77-97, 1994.